Uso de la inteligencia artificial en intervenciones en salud mental: implicancias clínicas y desafíos

Ali M, Ali S, Abbas Q, et al. Artificial intelligence for mental health: a narrative review of applications, challenges, and future directions in digital health. Digit Health. 2025;11. doi:10.1177/20552076251395548

Fitzpatrick KK, Darcy A, Vierhile M. Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (Woebot): a randomized controlled trial. JMIR Ment Health. 2017;4(2):e19. doi:10.2196/mental.7785

Prochaska JJ, Vogel EA, Chieng A, et al. A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic. Drug Alcohol Depend. 2021;227:108986. doi:10.1016/j.drugalcdep.2021.108986

Six S, Schlesener E, Hill V, et al. Impact of conversational and animation features of a mental health app virtual agent on depressive symptoms and user experience among college students: randomized controlled trial. JMIR Ment Health. 2025;12:e67381. doi:10.2196/67381

Torous J, Bucci S, Bell IH, et al. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry. 2021;20(3):318-35. doi:10.1002/wps.20883

Rahman A, Victoros E, Davis R, et al. Use of artificial intelligence in mental healthcare, health psychology, and related research: a narrative review to address challenges and opportunities. Health Sci Rep. 2025;8(12):e71595. doi:10.1002/hsr2.71595

Tabassum A, Ghaznavi I, Abd-Alrazaq A, et al. Exploring the application of AI and extended reality technologies in metaverse-driven mental health solutions: scoping review. J Med Internet Res. 2025;27:e72400. doi:10.2196/72400

Yoon SC, An JH, Choi JS, et al. Digital psychiatry with chatbot: recent advances and limitations. Clin Psychopharmacol Neurosci. 2025;23(4):542-50. doi:10.9758/cpn.25.1346